Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market
Holding CVKD?
Track your performance easily

Cadrenal Therapeutics, Inc. (CVKD) Stock News & Sentiment

74 Followers
Cadrenal Therapeutics Partners with Abbott on Cardiac Trial
Premium
Company Announcements
Cadrenal Therapeutics Partners with Abbott on Cardiac Trial
19d ago
Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
Premium
Company Announcements
Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
24d ago
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin
Premium
Company Announcements
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin
5M ago

News Score - Last 7 Days

Neutral
CVKD
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CVKD’s Media Buzz Sentiment?
3 articles about CVKD were published this week. In an average week, 2.25 articles are published.
    What is CVKD’s weekly average amount of articles?
    In an average week, 2.25 articles about CVKD are published.
      What is CVKD’s News Sentiment?
      50% of articles about CVKD were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        ANSLFAnsell
        ALKSAlkermes
        ARCTArcturus Therapeutics
        EBOEBOS Group Limited
        MDTMedtronic
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis